EGF Theramed Health Corp.
EVAHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $41 | $52 |
| SG&A Expenses | $23 | $7 | $41 | $67 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $15 |
| Other Operating Expenses | $0 | $0 | $35 | -$251 |
| Operating Expenses | $23 | $7 | $75 | -$184 |
| Operating Income | -$23 | -$7 | -$75 | $184 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$21 | -$1,511 | $0 | -$399 |
| Pre-Tax Income | -$44 | -$1,518 | -$75 | -$216 |
| Tax Expense | $0 | $608 | $0 | $4 |
| Net Income | -$35 | -$2,129 | -$70 | -$199 |
| % Margin | – | – | – | – |
| EPS | -0.003 | -0.18 | -0.006 | -0.017 |
| % Growth | 98.3% | -2,900% | 64.9% | – |
| EPS Diluted | -0.003 | -0.18 | -0.006 | -0.017 |
| Weighted Avg Shares Out | 11,617 | 11,617 | 11,617 | 11,617 |
| Weighted Avg Shares Out Dil | 11,617 | 11,617 | 11,617 | 11,617 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $13 | $16 | $14 | $13 |
| Depreciation & Amortization | $0 | $0 | $56 | $67 |
| EBITDA | -$31 | -$1,502 | -$4 | -$135 |
| % Margin | – | – | – | – |